Data/hora: 16/06/2024 06:29:00

Provedor de dados: 	60	
País: 	Brazil	
Título: 	Drugs obtained by biotechnology processing	
Autores: 	Almeida,Hugo; Amaral,Maria Helena; Lobão,Paulo.	
Data: 	2011-06-01	
Ano: 	2011	
Palavras-chave: 	Biotechnology; Recombinant DNA; Hybridoma technique; Bacteria; Antibiotics; Vaccines.	
Resumo: 	In recent years, the number of drugs of biotechnological origin available for many different diseases has increased exponentially, including different types of cancer, diabetes mellitus, infectious diseases (e.g. AIDS Virus / HIV) as well as cardiovascular, neurological, respiratory, and autoimmune diseases, among others. The pharmaceutical industry has used different technologies to obtain new and promising active ingredients, as exemplified by the fermentation technique, recombinant DNA technique and the hybridoma technique. The expiry of the patents of the first drugs of biotechnological origin and the consequent emergence of biosimilar products, have posed various questions to health authorities worldwide regarding the definition, framework, and requirements for authorization to market such products.	
Tipo: 	Info:eu-repo/semantics/article	
Idioma: 	Inglês	
Identificador: 	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502011000200002	
Editor: 	Universidade de São Paulo, Faculdade de Ciências Farmacêuticas	
Relação: 	10.1590/S1984-82502011000200002	
Formato: 	text/html	
Fonte: 	Brazilian Journal of Pharmaceutical Sciences  v.47 n.2 2011	
Fonte: 	info:eu-repo/semantics/openAccess